|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6200 AUD | 0.00% |
|
-3.88% | -16.22% |
| 30/04 | Aroa Biosurgery posts FY26 prelim total revenue of NZ$104 million | RE |
| 30/04 | Aroa Biosurgery Limited Provides Earnings Guidance for Fiscal Year 2026 | CI |
| Capitalization | 262M 156M 133M 122M 115M 213M 14.91B 214M 1.45B 565M 7.07B 584M 572M 24.59B | P/E ratio 2026 * |
73.6x | P/E ratio 2027 * | 34.8x |
|---|---|---|---|---|---|
| Enterprise value | 230M 137M 117M 107M 101M 187M 13.08B 188M 1.27B 496M 6.21B 513M 502M 21.57B | EV / Sales 2026 * |
2.21x | EV / Sales 2027 * | 1.86x |
| Free-Float |
72.46% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Aroa Biosurgery Limited
| 30/01/25 | Morgans rates ARX as Add | AQ |
| 22/05/24 | Morgans rates ARX as Add | AQ |
| 01/05/24 | Morgans rates ARX as Add | AQ |
| 30/11/22 | Aroa Biosurgery Half Yearly Report H1 FY23 | AQ |
| 30/11/22 | Aroa Biosurgery Announces Half Year Results | AQ |
| 1 week | -3.88% | ||
| Current month | -1.59% | ||
| 1 month | +21.57% | ||
| 3 months | -9.49% | ||
| 6 months | -13.89% | ||
| Current year | -16.22% |
| 1 week | 0.6 |  | 0.68 |
| 1 month | 0.5 | | 0.68 |
| Current year | 0.5 | | 0.78 |
| 1 year | 0.43 | | 0.8 |
| 3 years | 0.35 | | 1.02 |
| 5 years | 0.35 | | 1.3 |
| 10 years | 0.35 | | 1.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Ward
CEO | Chief Executive Officer | - | 01/01/2008 |
James Agnew
DFI | Director of Finance/CFO | - | 01/09/2013 |
Rod Stanley
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Ward
BRD | Director/Board Member | - | 01/01/2008 |
Philip McCaw
BRD | Director/Board Member | - | 05/03/2008 |
James McLean
CHM | Chairman | - | 10/08/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.88% | +37.78% | -33.33% | 156M | |
| -1.92% | -2.70% | -37.04% | -57.04% | 14.09B | |
| -7.69% | -6.15% | +116.01% | +107.42% | 4.78B | |
| +0.86% | -0.66% | +372.03% | +174.30% | 3.6B | |
| +0.06% | -0.34% | -38.27% | -24.99% | 2.73B | |
| 0.00% | -0.28% | -39.73% | -72.31% | 2.05B | |
| -1.19% | +15.28% | -2.35% | -20.95% | 1.71B | |
| 0.00% | +13.56% | -32.66% | -39.64% | 1.16B | |
| -0.82% | -16.53% | +40.84% | +6.34% | 1.1B | |
| +2.75% | +28.08% | +29.86% | +61.21% | 1.06B | |
| Average | -0.79% | +3.23% | +44.65% | +10.10% | 3.24B | |
| Weighted average by Cap. | -1.87% | -0.05% | +37.78% | +3.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 104M 61.72M 52.71M 48.3M 45.66M 84.55M 5.91B 84.99M 575M 224M 2.8B 232M 227M 9.74B | 119M 70.47M 60.19M 55.14M 52.13M 96.54M 6.74B 97.04M 657M 256M 3.2B 264M 259M 11.13B |
| Net income | 3.54M 2.1M 1.79M 1.64M 1.55M 2.88M 201M 2.89M 19.58M 7.62M 95.46M 7.89M 7.72M 332M | 7.96M 4.72M 4.03M 3.69M 3.49M 6.47M 452M 6.5M 43.99M 17.13M 214M 17.72M 17.34M 745M |
| Net Debt | -32.2M -19.11M -16.32M -14.95M -14.14M -26.18M -1.83B -26.32M -178M -69.32M -868M -71.71M -70.21M -3.02B | -42M -24.92M -21.29M -19.5M -18.44M -34.14M -2.39B -34.32M -232M -90.4M -1.13B -93.52M -91.56M -3.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/26 | 0.6200 $ | 0.00% | 73,351 |
| 13/05/26 | 0.6200 $ | 0.00% | 208,781 |
| 12/05/26 | 0.6200 $ | 0.00% | 137,763 |
| 11/05/26 | 0.6200 $ | -3.13% | 448,433 |
| 08/05/26 | 0.6400 $ | -0.78% | 187,314 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ARX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition